# Eurofins Lancaster Laboratories, Inc – FDA Inspection, Nov 4, 2016

Source: https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/19955c49-0273-4c87-b3d7-7aa5f1cbf109
Source feed: FDA_Inspections

> FDA inspection 1001348 of Eurofins Lancaster Laboratories, Inc, November 04, 2016. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001348
- Company Name: Eurofins Lancaster Laboratories, Inc
- Inspection Date: 2016-11-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1272016 - 2025-05-30](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/303e9119-e97b-46ac-953b-55ee592c5e2e)
- FDA Inspection 1160560 - 2021-12-10
- FDA Inspection 1080439 - 2019-01-23
- FDA Inspection 1045298 - 2018-02-23
- [FDA Inspection 889635 - 2014-08-01](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/efb068cd-3dde-4981-8fe6-60b3c544ac7c)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/charles-l-zhou/b55d1247-06de-4c7e-80d8-5ed2f801d259)
- [Constantin Y. Philopoulos](https://www.keypedia.com/people/constantin-y-philopoulos/536d53f5-7699-4b27-8b4b-10280cce9603)

Company: https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/a5676b12-3275-4a99-8f4b-3877e1728255

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
